2.40Open2.40Pre Close0 Volume1 Open Interest370.00Strike Price0.00Turnover276.49%IV43.77%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry2.40Extrinsic Value100Contract SizeAmericanOptions Type-0.0266Delta0.0003Gamma272.40Leverage Ratio-1.1566Theta-0.0025Rho-7.26Eff Leverage0.0469Vega
Millaai : Are you being trapped and looking for a rescuer everywhere?
Growth Investor27 : Good info, NEXLIZET is a great drug, my brother takes it. ESPR stock is undervalued, should be above $5
Growth Investor27 Millaai : The author has been buying below $2 so your comment is off. This research article has all the due diligence to see, other than the fact Institutions have been heavly buying this year, fintel shows now 74% owned. ESPR is a good investment.
104248191 : please f o